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Abstract An increased frequency of nontyphoidal salmo-
nellosis is well established in cancer patients, but it is
unclear whether this represents increased susceptibility to
exogenous infection or opportunistic, endogenous reacti-
vation of asymptomatic carriage. In a retrospective study, a
simple case definition was used to identify the probable
presence of reactivation salmonellosis in five cancer
patients between 1996 and 2002. Reactivation salmonel-
losis was defined as the development of nosocomial
diarrhea >72 h after admission and following the
administration of antineoplastic chemotherapy in an
HIV-seronegative cancer patient who was asymptomatic
on admission, in the absence of epidemiological evidence
of a nosocomial outbreak. Primary salmonellosis asso-
ciated with unrecognized nosocomial transmission or
community acquisition and an unusually prolonged incu-
bation period could not entirely be ruled out. During the
same time period, another opportunistic infection, Pneu-
mocystis pneumonia, was diagnosed in six cancer patients.
Presumably, asymptomatic intestinal Salmonella coloni-
zation was converted to invasive infection by chemother-
apy-associated intestinal mucosal damage and altered
innate immune mechanisms. According to published
guidelines, stool specimens from patients hospitalized for
longer than 72 h should be rejected unless the patient is
neutropenic or ≧65 years old with significant comorbidity.
However, in this study neutropenia was present in only
one patient, and four patients were <65 years old.
Guidelines should thus be revised in order not to reject
stool culture specimens from such patients. In cancer
patients, nosocomial salmonellosis can occur as a chemo-
therapy-triggered opportunistic reactivation infection that
may be similar in frequency to Pneumocystis pneumonia.
Introduction
In healthy persons, infection with nontyphoidal Salmo-
nella (NTS) causes no symptoms or a self-limited
gastroenteritis in >95% of cases. In the immunocompro-
mised host, however, severe cases with bacteremia and
metastatic infections may develop [1, 2]. Early diagnosis
and treatment are important, because the infection may be
life threatening [3]. It is well documented that NTS
infections occur more frequently in cancer patients [4–12].
In a recent case-control study [13], prior cytotoxic
chemotherapy or corticosteroid therapy was present more
frequently in children with NTS bacteremia than in
children with bacteremia caused by other Gram-negative
rods. However, it is unclear whether the increased
incidence of NTS infections in cancer patients is due to
an increased susceptibility to de novo, exogenous infec-
tion, including hospital-acquired salmonellosis, or to
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opportunistic reactivation of asymptomatic NTS stool
carriage induced by antineoplastic chemotherapy.
The aim of this retrospective study was to identify a
clinically useful method to differentiate between these
possibilities. Nosocomial transmission of NTS is rare in
Western countries [14, 15], and the typical incubation
period for NTS infection is 6–48 h [1, 2]. Therefore, in a
patient undergoing cancer chemotherapy, the onset of NTS
diarrhea more than 3 days after admission to the hospital,
in the absence of epidemiological evidence of nosocomial
transmission, would suggest chemotherapy-triggered re-
activation of asymptomatic NTS colonization. NTS stool
colonization has been found in 0.15–0.5% of asymptom-
atic individuals [16, 17]. A low inoculum may cause
colonization but no symptomatic infection, and <50% of
stool carriers report a previous diarrheal episode [2, 18].
Even in asymptomatic cases, stool excretion of NTS
continues for a median duration of 4–5 weeks in adults
and 7 weeks in children <5 years of age [16, 17, 19]. In
fact, 2–3% of convalescent adults and 15–32% of children
still excrete salmonellae at 6 months post infection. Thus,
a pool of asymptomatic carriers exists in the community at
any time.
Here we report five cancer patients admitted to our
medical center between 1996 and 2002 in whom chemo-
therapy-triggered reactivation seems the most likely
explanation of nosocomial NTS enteritis. Reactivation
salmonellosis in cancer patients has received no recent
attention in textbooks of infectious diseases, and no review
articles are available. However, we also found that the
frequency of reactivation salmonellosis may be similar to
that of another well-established opportunistic disease in
cancer patients, Pneumocystis carinii pneumonia (PCP)
[20].
Patients and methods
Medical records were reviewed for all patients who had at
least one stool culture positive for NTS and who were
hospitalized at the 814-bed University Hospital in
Lausanne, Switzerland, during the period of January
1996 to December 2002. Nontyphoidal salmonellae were
identified by standard microbiological criteria. Antimicro-
bial susceptibility testing was performed using the disk
diffusion method.
Of the patients with nontyphoidal salmonellosis, the
medical records of all cases with a concomitant diagnosis
of a malignant tumor were reviewed. A case of reactiva-
tion salmonellosis was diagnosed if a patient fulfilled all
four of the following criteria: (i) the patient was asymp-
tomatic on admission; (ii) bacteremia or diarrhea (defined
as ≥3 loose stools per day) due to NTS occurred more than
72 h after admission (thus, outpatient cases and cases
occurring within 72 h of admission were excluded, since it
would have been unclear if primary infection or reactiva-
tion disease was present); (iii) diarrhea or bacteremia
occurred after initiation of antineoplastic chemotherapy;
and (iv) there was no evidence of nosocomial acquisition
of the infection. Potential nosocomial NTS transmission
was investigated by the infection control service by review
of culture results in the microbiology laboratory and by
administration of a standardized questionnaire.
Documentation of asymptomatic NTS colonization
prior to initiation of chemotherapy was not used in the
case definition because routine stool cultures are not done
at our hospital prior to chemotherapy. HIV-seropositive
patients, patients infected with Salmonella enterica sero-
var Typhi or Paratyphi, and patients with insufficient
documentation were also excluded. Neutropenia and
lymphopenia were defined as an absolute neutrophil
count and lymphocyte count of <1,000/mm3 and 1,500/
mm3 (3,000 in children), respectively, at the time of the
positive culture for NTS.
To assess the frequency of PCP in cancer patients
during the same time period (1996–2002), we reviewed
the medical records of all HIV-seronegative patients with
morphological documentation of organisms in bronchoal-
veolar lavage fluid who had compatible clinical features, a
concomitant diagnosis of a malignant tumor, and had
received cancer chemotherapy or corticosteroids (in a dose
equivalent to ≥20 mg prednisone for ≥4 weeks) during the
6 months preceding the diagnosis of PCP.
Illustrative case report
A 28-year old woman (case 1, Table 1) was diagnosed as
having stage IIA diffuse large-B-cell lymphoma in January
2002. Complete remission was achieved after eight cycles
of CHOP (cyclophosphamide, doxorubicin, vincristine,
and prednisone). She relapsed in September 2002 and was
treated with three cycles of rituximab-ESHAP (etoposide,
cisplatine, cytarabine, methylprednisolone). During the
second cycle (45 days before admission), while at home,
the patient had an episode of watery diarrhea that resolved
spontaneously and for which she did not seek medical
attention. Peripheral stem cells were harvested, followed
by a conditioning regimen (BEAM: carmustine, cytara-
bine, etoposide, melphalan) between 28 November 2002
and 3 December 2002.
On 4 December, 7 days after starting chemotherapy and
1 day before peripheral blood stem cell infusion, the
patient developed severe diffuse crampy abdominal pain
and watery diarrhea. Her medical history was otherwise
unremarkable, and she was not taking any medications at
home. From September 2002 until the time of admission,
the patient received neither antibiotics nor antacids. There
were no known contacts with patients with diarrhea, no
exposure to animals, and no foreign travel, and the patient
had not eaten food brought from outside the hospital. The
patient’s temperature was 38.2°C. There was grade 2 oral
mucositis, and palpation of the right lower quadrant was
tender, with guarding. The leukocyte count was
2.2×10 cells/l (90% neutrophils, 10% lymphocytes).
Blood and urine cultures were sterile. Abdominal
computed tomography scan demonstrated wall thickening
of the entire colon.
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A presumptive diagnosis of early neutropenic entero-
colitis was made, and imipenem was started. Metronida-
zole was given until stool cultures and a cytotoxin assay
for Clostridium difficile were negative on three occasions.
The patient became overtly neutropenic (leukocytes,
2×10 cells/l) on 5 December. Stool cultures grew Salmo-
nella serovar Enteritidis, which was sensitive to amoxi-
cillin, trimethroprim/sulfamethoxazole, and ciprofloxacin.
It was possible that this enterocolitis represented reactiva-
tion of intestinal carriage after primary (but undocumen-
ted) Salmonella infection 45 days before admission.
Ciprofloxacin was added. During the next 6 days, the
fever, abdominal pain, and diarrhea persisted and the
absolute neutrophil count remained <500 cells/l, but the
patient’s condition remained stable. On 12 December, the
patient became afebrile and the abdominal pain and
diarrhea resolved concomitant with a rise in neutrophils to
1,100 cells/l. Imipenem was discontinued. Ciprofloxacin
was switched to the oral formulation to complete a 4-week
course of antibiotics. The patient recovered. At the most
recent follow-up visit (November 2003), she was asymp-
tomatic and in complete remission from her lymphoma.
Results
Between 1996 and 2002, 235 microbiological specimens
from 214 patients were culture positive for NTS in our
microbiology laboratory. The charts of ten patients with a
concomitant diagnosis of a malignant neoplasm were
reviewed. Of these, five patients were excluded because of
diarrhea or bacteremia that was already present on
admission to the hospital (n=3), HIV seropositivity
(n=1), or insufficient documentation (n=1). During the
same time period, Salmonella Typhi was recovered in
culture from ten specimens (from 9 patients), Salmonella
Paratyphi A from two specimens (2 patients), and
Salmonella Paratyphi C from one patient. None of these
patients had a concomitant diagnosis of a malignant cancer
and were therefore excluded from the analysis.
Five of the ten cancer patients with nontyphoidal
salmonellosis thus had an illness compatible with reacti-
vation disease following the administration of antineo-
plastic chemotherapy. The clinical details of these five
patients are summarized in Table 1. There were three
women, one female infant, and one man, and the median
age was 28 years (age range, 5 months to 73 years). Four
patients were asymptomatic on admission to the hospital.
On admission, patient 3 had a 1-month history of 2–3
semiformed stools per day, which was attributed to his
colon cancer. He was included in the analysis because of
the development of overt diarrhea (7–8 watery bowel
movements) and severe abdominal pain after receiving
chemotherapy. Overall, fever, abdominal pain, and diar-
rhea developed after chemotherapy in three, four, and five
patients, respectively.
There were no other nosocomial cases of NTS infection
during the hospital stay of any of the patients. NTS was
recovered from the stool of all five patients and from the
urine of one patient. Blood cultures were negative in three
patients and were not performed in two patients. No
definite metastatic infections were recorded. One patient
was neutropenic and lymphopenic at the time of positive
cultures, and two patients were lymphopenic only. No
reliable information regarding antibiotic or antacid treat-
ments in the past was available for four patients, but at the
time of hospital admission and until the diagnosis of NTS
enteritis, none of the patients received antibiotics. Salmo-
nellosis occurred during induction chemotherapy in three
patients and during intensification chemotherapy in two
patients.
All NTS isolates were sensitive to all antibiotics tested
(see footnote, Table 1). Nalidixic acid susceptibility testing
was not performed on any of the isolates. All patients were
successfully treated with antibiotics, with the treatment
duration ranging from 3 days to 4 weeks. Antineoplastic
therapy was continued in four patients after the recovery of
the NTS, while in patient 3, chemotherapy was discon-
tinued and palliative care initiated because of progressive
colon cancer. No relapses of NTS infection occurred
despite subsequent chemotherapy cycles in three patients.
The duration of follow-up ranged from 3 weeks to 52
months.
No patient had a prior history of documented NTS
infection, although an episode of diarrhea 45 days prior to
admission in patient 1 may have represented primary NTS
infection; stool cultures were not done at that time,
however. Asymptomatic stool colonization prior to reac-
tivation disease was recorded in one patient: Case 4 had
asymptomatic salmonelluria on routine urine culture prior
to chemotherapy (urine was collected for proteinuria
quantitation). No antibiotic treatment was administered
initially, and the patient developed enteritis following
administration of cyclophosphamide.
During the same time period (1996–2002), six cases of
PCP were diagnosed at our center in cancer patients
without HIV infection who had received antineoplastic
chemotherapy (n=4) or corticosteroids (n=2). None of
these six patients was receiving prophylaxis against PCP
at the time of PCP diagnosis.
Discussion
By use of a simple case definition, we identified the likely
presence of reactivation disease, as opposed to primary
infection, in five of ten cancer patients with nosocomial
NTS enteritis over a 7-year period. Precise incidence
estimates are not possible, given the unknown prevalence
of asymptomatic Salmonella colonization in our cancer
patients undergoing chemotherapy. Nonetheless, the fre-
quency of reactivation disease was similar to that of PCP
diagnosed during the same time period. Pneumocystis is an
opportunistic pathogen that is a rare but well established
cause of reactivated infection in cancer patients [20].
Reactivation salmonellosis has received little attention in
the recent literature. It most likely represents the conver-
sion of asymptomatic Salmonella stool colonization to
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invasive disease, triggered by cancer chemotherapy, via
damage to the gastrointestinal mucosa and alterations of
innate immune mechanisms [21]. Cancer chemotherapy
may thus “facilitate” the development of invasive salmo-
nellosis. This term was used by Barza and Travers [22] in
the context of prior antimicrobial therapy, which, by
reducing the normal flora, decreases resistance to coloni-
zation and thus facilitates infection by pathogenic bacteria.
On the other hand, it is also possible that antibiotics, e.g.,
PCP prophylaxis with trimethoprim/sulfamethoxazole
(TMP/SMX), might be effective in treating unrecognized
NTS colonization. Antibiotics might thereby prevent
reactivation of salmonellosis, at least in settings such as
ours, where TMP/SMX-susceptible strains predominate.
An increased occurrence of Salmonella infections in
cancer patients was documented in several reports
published between 1943 and 1969 [4–6, 8, 10, 11, 23].
None of these articles investigated, however, whether the
patients had primary infection or reactivation disease.
Nevertheless, in a report from 1994, 24 of 40 cancer
patients with salmonellosis had received prior chemother-
apy, and in 23 patients the infections were considered
nosocomial [7]. There are, however, three additional cases
of possible NTS reactivation in the literature [14, 24] in
which nosocomial acquisition cannot be excluded. One of
these patients [24] had reactivation bacteremia with
negative stool cultures, which may suggest an extraintest-
inal site of Salmonella latency, such as the reticuloendo-
thelial system [25]. Reactivation of salmonellosis that is
latent in the reticuloendothelial system may also explain
the higher frequency of salmonellosis in patients with
hematological malignancies than in patients with other
types of cancer [4–7].
Our experience suggests that reactivation salmonellosis,
when recognized, can be successfully treated even while
chemotherapy is continued. It has been reported pre-
viously that the continuation of antineoplastic therapy may
not worsen the severity of salmonellosis in children [9].
None of the patients had complications of salmonellosis
(such as bacteremia or metastatic infection), even though
blood cultures were done in only three of the five patients.
This is contrary to the notion that NTS infections may
follow a more serious course in immunocompromised
patients [1–3]. Potential explanations include the follow-
ing: (i) three patients developed NTS reactivation while
receiving induction chemotherapy and might be consid-
ered as only moderately immunosuppressed; (ii) the
salmonellosis, by definition, became apparent after
admission to the hospital in all patients, suggesting that
early detection by stool cultures in the inpatient setting and
timely administration of antibiotics could have prevented a
complicated course; and (iii) there were no cases due to
Salmonella Typhimurium, which, in some studies, has
been identified as a serovar more likely to be associated
with bacteremia [5, 8]. Whether neutropenia and lympho-
penia are predictors of more severe or protracted illness, as
in AIDS patients, is unclear.
Alternative explanations in these cases of nosocomial
salmonellosis include the possibility of primary commu-
nity-acquired Salmonella infection associated with an
unusually long incubation period. While an incubation
period for NTS enteritis of up to 72 h is consistently
reported in the literature, there are occasional older reports
of NTS outbreaks that have suggested incubation periods
of more than a week in a minority of affected patients.
However, such outbreaks either affected newborns [26] or,
in some cases, the seemingly long incubation period may
have been explained by secondary transmission or
microbiologically undocumented diarrheal illness that
was without a clear link to the outbreak in question [27,
28]
Nosocomial salmonellosis may also occur after eating
contaminated food from outside sources that is brought to
the hospital [29] or, with truly nosocomially acquired
infection, for instance, in association with eating hospital
food. No additional nosocomial cases of NTS infection
were found in any of our five patients after careful
epidemiological investigation. However, hospital-acquired
salmonellosis, even though rarely reported nowadays [15,
16], cannot be completely excluded. Current nutrition
guidelines at our hospital specify no food restrictions for
chemotherapy patients until they are neutropenic, at which
point no food containing raw eggs or raw meat is served.
The fact that three of our patients had enteritis due to
Salmonella Enteritidis is consistent with this being the
most common serovar in cases of sporadic NTS infection
in Switzerland and the serovar most consistently linked to
consumption of undercooked eggs [30].
An additional consideration is that the positive stool
cultures might incidentally have revealed a carrier state. A
possible pathogenic role of NTS is difficult to disregard,
however, in an immunocompromised patient with diarrhea
and severe abdominal pain. In patient 1, the presence of
bowel wall thickening on computed tomography scan and
the clinical recovery of the patient concomitant with
neutrophil recovery supported a diagnosis of neutropenic
enterocolitis [31]. In fact, the pathogenesis of NTS
reactivation enteritis may be similar to that of neutropenic
enterocolitis: Injury to the bowel mucosa (due to the
effects of chemotherapy, radiotherapy, or tumor infiltra-
tion) as well as impaired mucosal healing and altered
neutrophil function due to neutropenia may provide a
portal of entry for opportunistic invasion by endogenous
gut microorganisms, including gram-negative bacteria,
viridans streptococci, clostridia, or candida [32]. As in
NTS carriers with reactivation disease after chemotherapy,
unequivocal attribution of a pathogenic role of the
organisms implicated in neutropenic enterocolitis is
difficult since the same organisms can be found in the
stools of asymptomatic patients.
The concept of NTS reactivation is not new and has
been well documented in patients with conditions
characterized by macrophage dysfunction (such as malar-
ia, sickle cell disease, histoplasmosis, or bartonellosis
[11]) and after renal transplantation [32]. In a report from
Mexico [33], four of seven patients with systemic lupus
erythematosus who developed NTS arthritis following
treatment with cyclophosphamide and corticosteroids were
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asymptomatic stool carriers. NTS reactivation has also
been reported after major surgery [11, 13, 34]. Possible
underlying mechanisms include the facilitating effects of
prophylactic antibiotics, the immunosuppressive effect of
“stress” associated with surgery, and gastrointestinal stress
ulcers, which might permit invasive NTS infection. In
anecdotal reports since 1930, it has been repeatedly
observed that NTS may selectively infect tumor tissue [35,
36]. Presumably, necrotic cancer tissue may act as a fertile
ground for Salmonella superinfection, in conjunction with
defective immune surveillance at the site of the cancer.
Such events might further facilitate the occurrence of NTS
reactivation in cancer patients undergoing cancer chemo-
therapy. In order to take advantage of the apparent tropism
for cancer tissue, the potential antitumor activity of an
attenuated Salmonella Typhimurium strain is being
investigated in animal models [37] and in patients with
metastatic cancer in clinical trials [38, 39].
In contrast to NTS, the potential of Salmonella Typhi
and Paratyphi to cause reactivation disease in cancer
patients receiving chemotherapy is unclear. These organ-
isms were not involved in any of our patients and have
rarely been recovered from cancer patients, especially in
Western countries [5, 7] but also in endemic areas such as
Pakistan [40] or India [41]. The notion of chemotherapy-
associated reactivation could be difficult to prove for
Salmonella Typhi because of the longer incubation period
and because nosocomial transmission of Salmonella Typhi
is well documented in endemic areas [42, 43].
Nontyphoidal salmonellae are likely underreported as
causative agents of chemotherapy-associated diarrhea.
Stool cultures are infrequently obtained in chemotherapy
patients because they frequently develop diarrhea and
commonly are receiving or will soon receive antibiotics.
Even when NTS enteritis is considered, it may be missed
since three stool samples may be required to document
intestinal carriage [16, 44]. Nonetheless, Yuen et al. [45]
found NTS in the stools of five of 120 asymptomatic bone
marrow transplantation (BMT) candidates in Hong Kong.
Suppressive treatment with ciprofloxacin was successful
in all patients. NTS enteritis also occurred in three of 60
allogeneic BMT patients from England [46]. In two of
these three patients, salmonellosis occurred late, at the
time of stable engraftment. Differentiation of NTS enteritis
from the effects of intestinal graft-versus-host disease may
be difficult in this setting, but it is crucial, as a fatal case
has been reported [3]. Other studies of chemotherapy-
associated diarrhea may not have identified any cases due
to NTS because of the routine use of prophylactic
antibiotics [23, 47–49] or because the study was limited
to the period between days 20 and 150 after allogeneic
BMT, i.e., several weeks after the administration of
chemotherapy [49].
Bacterial stool cultures are expensive, and their yield in
patients hospitalized for more than 3 days is <2%.
Therefore, many hospitals reject stool culture specimens
from such patients (the “3-day rule”) [16, 44, 50]. Where
strict rejection rules are in place, however, physicians
should be aware that treatable cases of infectious diarrhea
may be missed, particularly in tertiary care centers treating
immunosuppressed patients [29]. In one prospective study
[44], 14.4% (53 of 369) of all Salmonella isolates were
cultured from stool specimens collected more than 3 days
after admission. Regardless of whether the patients with
nosocomial salmonellosis in this report ultimately had
reactivation of asymptomatic carriage or nosocomially
acquired disease, it is clear that the 3-day rule is
problematic. Nosocomial salmonellosis cases that are
missed due to the application of rules that require rejection
of stool cultures [51] may be complicated by bacteremia
and metastatic infection and may also lead to nosocomial
transmission to other immunocompromised patients. It has
been suggested that the 3-day rule be disregarded in
patients >65 years of age with significant comorbidity,
HIV infection, or neutropenia [16]. However, we show
here that nosocomial salmonellosis in cancer patients can
occur in the absence of neutropenia and in patients who
are <65 years old. Thus, nosocomial stool culture
guidelines should be modified to include cancer patients
who develop significant diarrhea and abdominal pain after
administration of chemotherapy.
As in patients with renal transplants [31] or systemic
lupus erythematosus [32], physicians should be aware of
the possibility of extended carriage with NTS in cancer
patients, along with the possibility of chemotherapy-
triggered reactivation. In medical centers such as ours,
where physicians can request exceptions to the 3-day
rejection rule, a high index of suspicion and close
communication between the treating physician and the
microbiology laboratory should facilitate identification of
cases. The optimal duration of antimicrobial treatment for
reactivation salmonellosis is unknown. Continuation of
antibiotics for at least the duration of neutropenia and for a
minimum of 10–14 days in bacteremic patients without
endovascular or metastatic infection [1, 2] may be a
prudent approach. Routine identification of the rare
carriers prior to cancer chemotherapy is unlikely to be
cost-effective. Further studies are required to determine the
incidence of reactivation salmonellosis in relation to
different chemotherapy regimens and to evaluate the best
approach when a carrier is identified prior to chemother-
apy (pre-chemotherapy eradication treatment versus pre-
emptive antimicrobial therapy if diarrhea occurs after
chemotherapy).
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